Document is current
Any future updates will be listed below
-
Authors
Wu, Qing-Juan
Lv, Wen-Liang https://orcid.org/0000-0002-4552-919X
Li, Juan-Mei
Zhang, Ting-Ting
Zhou, Wen-Hui
Zhang, Qiang
Wang, Jiu-Chong
Wang, Qing-Nan
Yao, Zi-Ang
Qiang, Rui
Chen, Si-Tong
Zhao, Xin
Liu, Shuang
Cao, Zheng-Min
Xu, Lei
Li, Gao-Hui
Chen, Jing
Wang, Li
-
Funding
Funding for this research was provided by:
the National Key R&D Program of China (2018YFC1705700)
- License Information
-
More Information
Article History
Received: 27 January 2021
Accepted: 23 September 2021
First Online: 14 October 2021
Declarations
:
: The protocol has been approved by the Medical Ethics Committee of Guang’anmen Hospital, China (which is the central ethical approval), and the other hospitals in the trial will not begin recruiting until the local ethical approval has been obtained. All study participants will sign two informed consent forms, one kept by the patients and the other one kept by the researcher. The results of this study will be published in a peer-reviewed journal.
: According to the terms of the informed consent, unless the subject’s consent is obtained, all the subject’s personal information is confidential and will not be disclosed to the public. When it is necessary, the drug supervision and administration department, ethics committee, or project funding department may consult the data of the subjects. If without permission, they will not use the subject’s information for other purposes or disclose it to other groups.
: All authors declare that they have no competing interests.
